1
To Study the Concentration Level of, Doxil, and Doxorubicin at Various Time Frames
Condition(s):Lymphoma LeukemiaLast Updated:June 5, 2019Unknown status
Liposomal Doxorubicin: 2472 Clinical Trials, Page 1 of 248
Hide Studies Not Open or Pending
2
Albumin-bound Paclitaxel Combined With Liposomal Doxorubicin in the Treatment of Advanced or Unresectable Angiosarcoma
Condition(s):Angiosarcoma MetastaticLast Updated:September 7, 2022Recruiting
3
Study on the Correlation Between Immunoglobulin and Liposomal Doxorubicin in Vivo
Condition(s):Advanced Malignant TumorsLast Updated:April 29, 2022Recruiting
4
A Study of Lapatinib in Combination With Caelyx in Patients With Advanced HER2 Positive Pretreated Breast Cancer
Condition(s):HER-2 Positive Breast Cancer; Malignant Neoplasm of BreastLast Updated:February 2, 2016Terminated
5
Anlotinib Hydrochloride Combined With Liposomal Doxorubicin in the Treatment of Locally Advanced or Metastatic Soft Tissue Sarcoma
Condition(s):SarcomaLast Updated:March 21, 2019Unknown status
6
Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma
Condition(s):Sarcoma, KaposiLast Updated:July 24, 2018Completed
7
Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian Cancer
Condition(s):Neoplasms, OvarianLast Updated:July 21, 2017Completed
8
MK-4827 in Combination With Pegylated Liposomal Doxorubicin in Participants With Advanced Solid Tumors and Ovarian Cancer (MK-4827-011)
Condition(s):Ovarian CancerLast Updated:October 19, 2016Terminated
9
Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Patients With Advanced Hepatocellular Cancer
Condition(s):Liver NeoplasmsLast Updated:July 4, 2013Withdrawn
10
Neoadjuvant Chemotherapy With a Combination of Pegylated Liposomal Doxorubicin (Caelyx®) and Paclitaxel in Breast Cancer
Condition(s):Breast CancerLast Updated:July 19, 2017Completed